🇺🇸 FDA
Pipeline program

ANAWIDOW [antivenin latrodectus (black widow) equine immune F(ab)2] lyophilized powder for solution 10 mL

AS/BW/ENE-21/0003

Phase 1 small_molecule completed

Quick answer

ANAWIDOW [antivenin latrodectus (black widow) equine immune F(ab)2] lyophilized powder for solution 10 mL for Latrodectism is a Phase 1 program (small_molecule) at Ultragenyx Pharmaceutical with 1 ClinicalTrials.gov record(s).

Program details

Company
Ultragenyx Pharmaceutical
Indication
Latrodectism
Phase
Phase 1
Modality
small_molecule
Status
completed

Clinical trials